|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/48 | |
| C07K 14/755 | |||
| A61K 38/37 | |||
| A61P 7/04 |
| (11) | Patento numeris | 2257311 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09714286.3 |
| Europos patento paraiškos padavimo data | 2009-02-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-12-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-04-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/035339 |
| Data | 2009-02-26 |
| (87) | Numeris | WO 2009/108806 |
| Data | 2009-09-03 |
| (30) | Numeris | Data | Šalis |
| 32006 | 2008-02-27 | US | |
| 43354 | 2008-04-08 | US | |
| 58869 | 2008-06-04 | US |
| (72) |
DEFREES, Shawn, US
VANDAHL, Brian, Berg, Stidsen, DK
BOLT, Gert, DK
STENNICKE, Henning, Ralf, DK
THIM, Lars, DK
STEENSTRUP, Thomas, Dock, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | CONJUGATED FACTOR VIII MOLECULES |
| CONJUGATED FACTOR VIII MOLECULES |